In 2024, China's share of the world's 10% top-cited publications in pharmacy is forecasted at 16.27%, indicating a steady rise from the previous years' levels. This upward trend continues through 2028 with anticipated shares reaching 19.9%. The year-on-year growth suggests consistent strength in China's scientific research output, with a CAGR of approximately 4.4% over five years. This projection reflects China's increased focus on enhancing its pharmacy research capabilities.
Future trends to watch for:
- Impact of policy changes on research funding and innovation.
- Partnerships and collaborations enhancing global research influence.
- Technological advancements driving publication quality and citation rates.
